The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
National Eosinophilia Myalgia Syndrome Network, Inc.
767 Tower Boulevard
Lorain, OH 44052-5213
The National Eosinophilia-Myalgia Syndrome Network, Inc., (NEMSN) is a non-profit organization founded in 1995 to help eosinophilia myalgia syndrome (EMS) survivors and their families. EMS has been associated with the ingestion of large amounts of contaminated L-tryptophan, a dietary supplement often sold in health food stores. It is a disease of abrupt onset causing severe, disabling, chronic muscle pain, skin symptoms and other neurotoxic reactions. The NEMSN offers patient education, networking and advocacy to patients in the United States, Canada, the UK, Australia, and other areas though the Internet. NEMSN also offers information and education to health professionals.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and that credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions are strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.